摘要
目的 研究探讨单药应用丙戊酸、奥卡西平和左乙拉西坦三种抗癫痫药物对学龄期癫痫患儿临床疗效和骨代谢水平的影响。方法 选取2015年6月-2018年6月保定市儿童医院收治的学龄期癫痫患儿150例,采用随机数表法分为3组,每组各50例,A组给予奥卡西平,B组给予左乙拉西坦,C组给予丙戊酸,均进行单药治疗,治疗6个月后,评价并比较三组疗效及治疗前后骨代谢指标水平变化情况。结果 治疗后与治疗前比较,A组血清Ca与25-(OH)D水平下降、ALP水平升高、差异有统计学意义(t=21.125、4.037、4.976,P＜0.001);B组仅ALP水平显著升高(t=2.321,P＜0.05);C组血清Ca、25-(OH)D与BMD水平显著下降、ALP与BAP水平显著升高(t=31.596、5.991、3.591、3.239、4.643,P＜0.001)。三组间治疗总有效率比较差异有统计学意义(P＜0.05)。结论 对于癫痫患儿,左乙拉西坦在疗效上优于丙戊酸,在不良反应上优于奥卡西平,且对学龄期患儿的骨代谢指标影响也为最小,安全有效,值得应用。
Abstract
Objective To investigate the efficacy of three antiepileptic drugs on epilepsy,including valproic acid,oxcarbazepine and levetiracetam,and to analyze their effects on bone metabolism of children with school-age children. Methods A total of 150 school-age children with epilepsy admitted to Baoding Children′s Hospital were enrolled in this study from June 2015 to June 2018,and were randomly divided into three groups,with 50 cases in each group.Group A received oxcarbazepine,group B received levetiracetam,while group C was given valproic acid for monotherapy.After 6 months of treatment,the efficacy of three drugs was evaluated.The changes in bone metabolic markers before and after intervention were compared. Results After treatment,the levels of Ca and 25- (OH) D in group A significantly decreased,while ALP level significantly increased (t=21.125,4.037,4.976,P＜0.001).ALP level in group B was significantly higher after treatment (t=2.321,P＜0.05).Moreover,the levels of Ca,25- (OH)D and BMD in group C significantly decreased after treatment,while the levels of ALP and BAP significantly increased after treatment (t=31.596,5.991,3.591,3.239,4.643,P＜0.001).The total effective rates of three groups were significantly different (P＜0.05). Conclusions For children with epilepsy,the efficacy of levetiracetam is superior to that of valproic acid,and the adverse reaction of levetiracetam is less than oxcarbazepine.It is worth noting that levetiracetam has the least impact on bone metabolism indicators in school-age children.Because of its safety and effectiveness,levetiracetam is worth of clinical application.
关键词
丙戊酸 /
奥卡西平 /
左乙拉西坦 /
单药治疗 /
学龄期 /
癫痫 /
骨代谢
Key words
valproic acid /
oxcarbazepine /
levetiracetam /
monotherapy /
school-age /
epilepsy /
bone metabolism
张小龙, 张远达, 何华芬, 冀超玉, 杨旭, 任淑红.
丙戊酸、奥卡西平、左乙拉西坦单药治疗对学龄期癫痫患儿的疗效及骨代谢水平影响[J]. 中国儿童保健杂志. 2020, 28(3): 331-334 https://doi.org/10.11852/zgetbjzz2019-0451
ZHANG Xiao-long, ZHANG Yuan-da, HE Hua-fen, JI Chao-yu, YANG Xu, REN Shu-hong.
Effects of valproic acid,oxcarbazepine and levetiracetam monotherapy on the efficacy and bone metabolism of school-age children with epilepsy[J]. Chinese Journal of Child Health Care. 2020, 28(3): 331-334 https://doi.org/10.11852/zgetbjzz2019-0451
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 王加朋,梁彩艳.丙戊酸钠、奥卡西平与左乙拉西坦分别治疗小儿癫痫的疗效及对认知功能的影响[J].药物评价研究,2017,40(5):687-690.
[2] 满丽娜,王坤,栾馥.左乙拉西坦联合奥卡西平治疗小儿癫痫的效果、不良反应及脑电图改善情况[J].实用临床医药杂志,2017,21(1):174-175.
[3] 黄琳,赵京玉,文睿婷,等.左乙拉西坦治疗妊娠期癫痫疗效及胎儿安全性的Meta分析[J].中国医院药学杂志,2017,37(1):43-47.
[4] 黄晓婧,高乃君,顾群,等.奥卡西平单药治疗对癫痫患者骨代谢影响的系统评价[J].中国药学杂志,2017,52(16):1465-1469.
[5] 抗癫痫药物对卒中后癫痫患者血清同型半胱氨酸、叶酸、B族维生素水平的影响[J].临床神经病学杂志,2017,30(2):93-97.
[6] 刘远昌.两种抗癫痫单药方案对部分性发作癫痫患儿临床疗效及安全性[J].临床军医杂志,2017,45(11):1171-1173.
[7] 赵婷,李红健,王婷婷,等.年龄、性别、族别及联合用药对新疆癫痫患儿左乙拉西坦血药浓度的影响[J].中国医院药学杂志,2017,37(12):1174-1178.
[8] 季茉.左乙拉西坦治疗小儿癫痫临床疗效及对脑电图、智力改善作用[J].临床军医杂志,2017,45(8):865-867.
[9] 孙威.左乙拉西坦单药治疗癫痫患儿临床效果及其对骨代谢的影响[J].中国伤残医学,2017,25(19):55-56.
[10] 方舒,龚志成.奥卡西平的不良反应[J].中国当代儿科杂志,2015,17(4):414-419.
[11] 刘淼.丙戊酸、左乙拉西坦单药治疗对学龄前期及学龄期儿童骨代谢的影响[J].临床应用研究,2017,32(12):944-946.
PDF(692 KB)
